Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2004 May;111(5):485-90.
doi: 10.1111/j.1471-0528.2004.00117.x.

A population-based evaluation of the impact of antenatal screening for Down's syndrome in France, 1981-2000

Babak Khoshnood  1 , Catherine De Vigan, Véronique Vodovar, Janine Goujard, François Goffinet
Affiliations

A population-based evaluation of the impact of antenatal screening for Down's syndrome in France, 1981-2000

Babak Khoshnood et al. BJOG. 2004 May.

Abstract

Objective: To evaluate the impact of policy and practice changes in prenatal screening for Down's syndrome on prenatal diagnosis and live birth prevalence of Down's syndrome.

Design: Population-based observational study.

Setting: Greater Paris.

Population: Residents of Greater Paris who gave birth or had a termination of pregnancy in Paris during 1981-2000 (approximately 38,000 births per year).

Methods: Data on 1916 cases of Down's syndrome were obtained from the Paris Registry of Congenital Anomalies. Analyses included binomial and Poisson models of trends in three periods: prior to 1989 (reference period), 1989-1995 (reimbursement of amniocentesis in case of ultrasonographic anomalies) and 1996-2000(widespread use of reimbursed serum screening and measurement of nuchal translucency).

Main outcome measures: Trends in proportion of Down's syndrome cases diagnosed prior to birth; live birth prevalence of Down's syndrome.

Results: The proportion of Down's syndrome detected prenatally for women <38 years of age increased ninefold; from 9.5% (95% CI 2.7-22.6) in 1981 to 84.9% (95% CI 74.6-92.2) in 2000. For women >38 years of age, the increase was 1.5-fold. The live birth prevalence of Down's syndrome decreased by 3% per year (prevalence ratio [PR] 0.97, 95% CI 0.96-0.99); the age-adjusted decrease was 13%. The analysis by period showed that the decrease in live birth prevalence of Down's syndrome was greater after 1988.

Conclusions: By far, most cases of Down's syndrome are currently detected prenatally in the Parisian population. Consequently, the live birth prevalence of Down's syndrome has decreased despite consistent trends towards delayed childbearing. These positive public health effects have to be balanced against a relatively high rate of amniocentesis and the potentially negative consequences of widespread prenatal testing for individuals born with Down's syndrome.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Three year moving average trends in the proportion of Down’s syndrome cases detected prior to birth, Paris Registry of Congenital Malformations, 1983–2000. Arrows indicate the years (1988 and 1996) in which important changes took place with regard to prenatal testing policy in France (see text for additional details).
Figure 2
Figure 2
Trends in prevalence of Down’s syndrome, Paris Registry of Congenital Malformations, 1981–2000.
See this image and copyright information in PMC

References

    1. Wald NJ, Watt HC, Hackshaw AK. Integrated screening for Down’s syndrome on the basis of tests performed during the first and second trimesters. N Engl J Med. 1999;341(7):461–467. - PubMed
    1. Nicolaides KH, Heath V, Cicero S. Increased fetal nuchal translucency at 11–14 weeks. Prenat Diagn. 2002;22(4):308–315. - PubMed
    1. Proceedings of the EUCROMIC Workshop on Prenatal Diagnosis. . Paris, May 23–24, 1996. Eur J Hum Genet. 1997;5 (Suppl 1):1–90. - PubMed
    1. Wellesley D, Boyle T, Barber J, Howe DT. Retrospective audit of different antenatal screening policies for Down’s syndrome in eight district general hospitals in one health region. BMJ. 2002;325(7354):15. - PMC - PubMed
    1. Ayme S, Morichon N, Goujard J, Nisand I. Prenatal diagnosis in France. Eur J Hum Genet. 1997;5(suppl 1):26–31. - PubMed

Publication types